These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride. Reveno WS; Bauer RB; Rosenbaum H Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462 [No Abstract] [Full Text] [Related]
4. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes]. Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408 [No Abstract] [Full Text] [Related]
5. Combined treatment of parkinsonism with L-dopa and amantadine. Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690 [No Abstract] [Full Text] [Related]
6. [Amantadine treatment in parkinsonism]. Holmsen R Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2118-9. PubMed ID: 4773984 [No Abstract] [Full Text] [Related]
7. Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa. Timberlake WH; Vance MA Ann Neurol; 1978 Feb; 3(2):119-28. PubMed ID: 350129 [TBL] [Abstract][Full Text] [Related]
8. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism. Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599 [No Abstract] [Full Text] [Related]
9. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism. Mindham RH; Gaind R; Anstee BH; Rimmer L Psychol Med; 1972 Nov; 2(4):406-13. PubMed ID: 4571143 [No Abstract] [Full Text] [Related]
11. [Amantadine in the treatment of Parkinson's disease]. Penders C Rev Med Liege; 1972 Dec; 27(23):835-7. PubMed ID: 4276353 [No Abstract] [Full Text] [Related]
12. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. Schwab RS; England AC Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453 [No Abstract] [Full Text] [Related]
13. Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy. Callagham N; Mcllroy M; O'Connor M Ir J Med Sci; 1974 Mar; 143(2):67-78. PubMed ID: 4617744 [No Abstract] [Full Text] [Related]
14. Visual hallucinations and delirium during treatment with amantadine (Symmetrel). Postma JU; Van Tilburg W J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540 [TBL] [Abstract][Full Text] [Related]
15. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial. Appleton DB; Eadie MJ; Sutherland JM Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572 [No Abstract] [Full Text] [Related]
16. Trial of amantadine in Parkinson's disease. Campbell AM; Williams MJ Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563 [No Abstract] [Full Text] [Related]
18. Treatment of Parkinson's disease with amantadine and L-Dopa. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618 [No Abstract] [Full Text] [Related]
19. [Amantadine and dexetimide in the treatment of parkinsonism]. Hakkarainen H; Viukari M Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970 [No Abstract] [Full Text] [Related]
20. Livedo reticularis in Parkinson's disease patients treated with amantadine hydrochloride. Silver DE; Sahs AL Neurology; 1972 Jul; 22(7):665-9. PubMed ID: 4673247 [No Abstract] [Full Text] [Related] [Next] [New Search]